Pfizer Inc Cash Flow Quality Index
Pfizer Inc cash flow quality index. Pfizer Inc (PFIZ34) has a Cash Flow Quality Index of 0.97x as of March 2026. Operating cash flow of R$2.62 Billion is below net income of R$2.69 Billion, suggesting accrual-heavy earnings not yet converted to cash. See Pfizer Inc (PFIZ34) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Pfizer Inc (2014–2025)
Cash flow quality index of Pfizer Inc from 2014 to 2025. Historical Cash Flow Quality Index for Pfizer Inc across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Pfizer Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Pfizer Inc Cash Flow Quality Index by Year (2014–2025)
Pfizer Inc cash flow quality index by year from 2014 to 2025. Year-by-year earnings quality comparison for Pfizer Inc. For the full cash flow conversion analysis, see how efficiently does Pfizer Inc generate cash.
| Year | Quality Index | Operating CF (BRL) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.50x | R$11.71 Billion | R$7.81 Billion | ▼ -5.6% |
| 2024 | 1.59x | R$12.74 Billion | R$8.03 Billion | ▼ -72.1% |
| 2023 | 5.68x | R$12.04 Billion | R$2.12 Billion | ▲ +509.2% |
| 2022 | 0.93x | R$29.27 Billion | R$31.37 Billion | ▼ -37.1% |
| 2021 | 1.48x | R$32.58 Billion | R$21.98 Billion | ▼ -0.7% |
| 2020 | 1.49x | R$14.40 Billion | R$9.65 Billion | ▲ +93.3% |
| 2019 | 0.77x | R$12.59 Billion | R$16.30 Billion | ▼ -45.4% |
| 2018 | 1.41x | R$15.83 Billion | R$11.19 Billion | ▲ +79.8% |
| 2017 | 0.79x | R$16.80 Billion | R$21.36 Billion | ▼ -64.8% |
| 2016 | 2.23x | R$16.19 Billion | R$7.25 Billion | ▲ +5.9% |
| 2015 | 2.11x | R$14.69 Billion | R$6.96 Billion | ▲ +12.8% |
| 2014 | 1.87x | R$17.08 Billion | R$9.13 Billion | — |